EFFECT OF GLIPIZIDE TREATMENT ON RESPONSE TO AN INFUSED GLUCOSE-LOAD IN PATIENTS WITH NIDDM

被引:5
作者
SHEU, WHH [1 ]
JENG, CY [1 ]
FUH, MMT [1 ]
CHEN, YDI [1 ]
REAVEN, GM [1 ]
机构
[1] STANFORD UNIV,SCH MED,DEPT MED,PALO ALTO,CA 94304
关键词
D O I
10.2337/diacare.18.12.1582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - This study was initiated to compare the effect of sulfonylurea treatment on the response to an infused glucose load of patients with non-insulin-dependent diabetes mellitus (NIDDM) at a basal insulin concentration and in response to physiological hyperinsulinemia. RESEARCH DESIGN AND METHODS - We used the insulin suppression test, in which subjects were infused for 180 min with somatostatin, exogenous insulin, and glucose. Since similar steady-state plasma insulin (SSPI) concentrations are reached in all subjects, the resultant steady-state plasma glucose (SSPG) concentration permits comparison of the ability of a given individual to maintain glucose homeostasis in response to the infused glucose load. RESULTS - We studied 15 nonobese patients at two different SSPI concentrations, before and after glipizide treatment, at basal (68 +/- 4 pmol/l) and high (470 +/- 31 pmol/l) levels. Values for SSPG concentrations were lower after treatment at both the basal (15.3 +/- 0.5 vs. 18.5 +/- 0.6 mmol/l; P < 0.001) and the high (10.6 +/- 0.7 vs. 14.2 +/- 0.7 mmol/l; P < 0.001) SSPI concentrations. To compare the responses of each patient before and after treatment, we calculated the fractional glucose metabolic rate, i.e., (glucose infusion rate - urinary glucose loss) divided by SSPG. To provide an alternative method of comparing the effect of sulfonylurea treatment, we divided the incremental increase in fractional metabolic glucose rate between the studies done at the low and high SSPI by the incremental increase in SSPI between the two studies (insulin sensitivity index [S-1]). CONCLUSIONS - The results of these calculations indicated that glipizide treatment was associated with a significant increase in fractional glucose metabolic rate at a basal insulin concentration (29 +/- 3 to 42 +/- 2 ml . m(-2) . min(-1), P < 0.001), and in response to the incremental change in SSPI (14 +/- 4 to 23 +/- 3 ml . m(-2) . min(-1), P < 0.02). Finally, S-1 also increased in association with sulfonylurea (0.24 +/- 0.06 to 0.43 +/- 0.07 ml . m(-2) . min(-1)/mu U . ml(-1), P < 0.001).
引用
收藏
页码:1582 / 1587
页数:6
相关论文
共 18 条
  • [1] EFFECT OF HYPERGLYCEMIA PER-SE ON GLUCOSE DISPOSAL AND CLEARANCE IN NONINSULIN-DEPENDENT DIABETICS
    BEST, JD
    BEARD, JC
    TABORSKY, GJ
    HALTER, JB
    PORTE, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (04) : 819 - 823
  • [2] GLUCOSE DISPOSAL IS NOT PROPORTIONAL TO PLASMA-GLUCOSE LEVEL IN MAN
    BEST, JD
    TABORSKY, GJ
    HALTER, JB
    PORTE, D
    [J]. DIABETES, 1981, 30 (10) : 847 - 850
  • [3] EFFECT OF VARIATIONS IN BASAL PLASMA-GLUCOSE CONCENTRATION ON GLUCOSE-UTILIZATION (M) AND METABOLIC-CLEARANCE (MCR) RATES DURING INSULIN CLAMP STUDIES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    DOBERNE, L
    GREENFIELD, MS
    ROSENTHAL, M
    WIDSTROM, A
    REAVEN, G
    [J]. DIABETES, 1982, 31 (05) : 396 - 400
  • [4] PRESENTATION OF A NEW METHOD FOR SPECIFIC MEASUREMENT OF INVIVO INSULIN-STIMULATED GLUCOSE DISPOSAL IN HUMANS - COMPARISON OF THIS APPROACH WITH THE INSULIN CLAMP AND MINIMAL MODEL TECHNIQUES
    DONNER, CC
    FRAZE, E
    CHEN, YDI
    HOLLENBECK, CB
    FOLEY, JE
    REAVEN, GM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) : 723 - 726
  • [5] DEMONSTRATION OF INSULIN RESISTANCE IN UNTREATED ADULT ONSET DIABETIC SUBJECTS WITH FASTING HYPERGLYCEMIA
    GINSBERG, H
    KIMMERLING, G
    OLEFSKY, JM
    REAVEN, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (03) : 454 - 461
  • [6] EFFECT OF SULFONYLUREA TREATMENT ON INVIVO INSULIN-SECRETION AND ACTION IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    GREENFIELD, MS
    DOBERNE, L
    ROSENTHAL, M
    SCHULZ, B
    WIDSTROM, A
    REAVEN, GM
    [J]. DIABETES, 1982, 31 (04) : 307 - 312
  • [7] ASSESSMENT OF INSULIN RESISTANCE WITH THE INSULIN SUPPRESSION TEST AND THE EUGLYCEMIC CLAMP
    GREENFIELD, MS
    DOBERNE, L
    KRAEMER, F
    TOBEY, T
    REAVEN, G
    [J]. DIABETES, 1981, 30 (05) : 387 - 392
  • [8] IMMUNOASSAY OF INSULIN WITH INSULIN-ANTIBODY PRECIPITATE
    HALES, CN
    RANDLE, PJ
    [J]. BIOCHEMICAL JOURNAL, 1963, 88 (01) : 137 - &
  • [9] TREATMENT OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - DIABETIC CONTROL AND INSULIN-SECRETION AND ACTION AFTER DIFFERENT TREATMENT MODALITIES
    HOLLENBECK, CB
    REAVEN, GM
    [J]. DIABETIC MEDICINE, 1987, 4 (04) : 311 - 316
  • [10] HOW DOES GLIBENCLAMIDE LOWER PLASMA-GLUCOSE CONCENTRATION IN PATIENTS WITH TYPE-2 DIABETES
    JENG, CY
    HOLLENBECK, CB
    WU, MS
    CHEN, YDI
    REAVEN, GM
    [J]. DIABETIC MEDICINE, 1989, 6 (04) : 303 - 308